What are the complication rates of transvenous stenting in Idiopathic Intracranial Hypertension (IIH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Transvenous stenting in Idiopathic Intracranial Hypertension (IIH) has a complication rate that includes short-lived ipsilateral headache, stent-adjacent stenosis, vessel perforation, stent migration, and thrombosis.

Common Complications

  • Short-lived ipsilateral headache is a common complication, occurring in many patients 1
  • Stent-adjacent stenosis requiring retreatment occurs in approximately a third of patients 1

Rare but Serious Complications

  • Vessel perforation leading to acute subdural haematoma is a rare but serious complication 1
  • Stent migration and thrombosis are also rare complications 1

Management Considerations

  • Long-term antithrombotic therapy is required for longer than 6 months following neurovascular stenting treatment to prevent thrombotic complications 1 It is essential to note that the role of neurovascular stenting in IIH is not yet established, and the decision to proceed with this treatment should be made on a case-by-case basis, weighing the potential benefits against the risks of complications 1.

From the Research

Complication Rates of Transvenous Stenting in IIH

The complication rates of transvenous stenting in Idiopathic Intracranial Hypertension (IIH) have been reported in several studies:

  • A study published in 2022 2 reported six major acute and chronic complications after venous sinus stenting (VSS) for IIH, including acute subdural hematoma, stent thrombosis, cerebellar hemorrhage, venous microcatheter perforation, and subarachnoid hemorrhage.
  • A meta-analysis published in 2024 3 found that the complication rate after VSS was 5.35%, including subdural hemorrhage, urinary tract infection, stent thrombus formation, and others.
  • A study published in 2018 4 reported a complication rate of 4.9% after dural venous sinus stent (DVSS) insertion, with at least 20% of patients developing restenosis following DVSS.
  • A review of the literature published in 2013 5 found a total of nine complications (6%) in 143 patients with IIH treated with venous sinus stenting.
  • A study published in 2014 6 identified risk factors for failed transverse sinus stenting in pseudotumor cerebri patients, including highly elevated opening pressure pre-stenting and persistent papilledema post-stenting.

Types of Complications

The types of complications reported in these studies include:

  • Subdural hematoma
  • Stent thrombosis
  • Cerebellar hemorrhage
  • Venous microcatheter perforation
  • Subarachnoid hemorrhage
  • Urinary tract infection
  • Restenosis
  • Stent failure

Frequency of Complications

The frequency of complications reported in these studies varies:

  • 5.35% complication rate after VSS 3
  • 4.9% complication rate after DVSS 4
  • 6% complication rate in 143 patients with IIH treated with venous sinus stenting 5
  • 3 patients (16.7%) required shunt placement after failed transvenous stenting 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.